Form 4 Filing: Mottola Frank Acquires shares of SUPERNUS PHARMACEUTICALS, INC.

INSIDER TRANSACTION

⚡ MATERIALITY: 1/10

corporate issuer

SUPERNUS PHARMACEUTICALS, INC.

Ticker: not matched

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-11-02

Shares: 19,544

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Mottola Frank, holds the title of SVP, Chief Tech. Ops. Officer at SUPERNUS PHARMACEUTICALS, INC..

On 2026-11-02, the insider transacted 19,544 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Mottola Frank (SVP, Chief Tech. Ops. Officer) transacted $0 of $SUPN

Post-Transaction Position: 0 shares

SEC Accession No: 0001804567-26-000018 (CIK: 1804567)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

OpenCorporates RegistryVerify Corporate Identity

Google NewsSUPERNUS PHARMACEUTICALS, INC. News Coverage